Weld Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,852
Closed -$204K 631
2020
Q3
$204K Sell
5,852
-3,180
-35% -$111K 0.08% 388
2020
Q2
$280K Buy
+9,032
New +$307K 0.11% 299
2020
Q1
Sell
-25,674
Closed -$954K 638
2019
Q4
$954K Buy
+25,674
New +$914K 0.18% 194

Other funds holding PFE

Weld Capital Management's PFE Position: Q4 2020 in Review

Weld Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 5,852 shares — an estimated $204K sold.

Weld Capital Management first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $954K in Q4 2019. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Weld Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Weld Capital Management sold 5,852 Pfizer shares in Q4 2020, an estimated $204K.
  • Weld Capital Management first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
  • Weld Capital Management's Pfizer position peaked at $954K in Q4 2019.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.